Korea Advanced Institute of Science and Technology and New York University have unveiled the official signage of their joint campus to mark the beginning of a new global academic partnership, KAIST announced Thursday. Under the partnership, the two universities will begin joint research in the first half of next year with a focus on artificial intelligence, convergence neuroscience, biomedical engineering, cybersecurity, next-generation wireless communication and sustainability. The schools also

Technology Sept. 22, 2022

South Korean researchers have discovered how early diagnosis and medication may help ease symptoms of those with autism spectrum disorder, the Institute of Basic Science said Wednesday. Autism is a type of brain development disorder found in about 2 percent of the world population, according to the IBS. Common symptoms include a lack of social communication and interaction skills as well as repetitive behaviors and unexpected reactions. The exact cause of autism and its treatment still remain u

Technology Sept. 21, 2022

South Korea will spend 200 billion won ($144 million) on digital integration strategy projects over the next five years to shorten the time researchers take to solve complex problem surrounding new technologies by decades, the Ministry of Science said Tuesday. According to the ministry, the government will use the financial support for projects that integrate artificial intelligence, digital twin and big data into developing diagnoses of diseases such as intractable cancer and dementia, nine ne

Technology Sept. 20, 2022

The Medicines and Healthcare products Regulatory Agency -- the UK’s drug authorization body -- has granted Celltrion sales approval for oncology biosimilar Vegzelma in the country, the South Korean company announced Monday. According to Celltrion, Vegzelma was authorized for the treatment of multiple types of cancer including metastatic breast cancer, non-small cell lung cancer, ovarian cancer and cervical cancer. The UK approval came a month after Vegzelma received a green light from th

Technology Sept. 19, 2022

South Korea will cut down the time it takes to complete the review process for national research and development projects to 4 1/2 months from the current seven-month period to secure the timeliness of certain projects, the Ministry of Science and ICT said Friday, as it announced the revised policies to enhance the country’s preliminary feasibility study for R＆D projects. According to the ministry, projects that will be subject to the new review policy will be limited to those that pass th

Technology Sept. 18, 2022

US President Joe Biden’s executive order on bolstering the country's biotechnology and biomanufacturing sectors with over $2 billion in spending will not dampen the outlook for the South Korean bio industry, according to industry insiders and analysts. The US-first initiative could rather serve as an opportunity for Korean companies, they said. “The US’ move appears to be another attempt to solidify the ‘made-in-America’ efforts, similar to the electric vehicle and

Technology Sept. 18, 2022

LG Uplus, South Korea’s third-largest telecom operator by market share, has pledged to increase the sales proportion of non-telecommunication services to 40 percent of the total by 2027 with a focus on developing platform businesses. “Now moving beyond the area of traditional telecom businesses, we are looking to open up the era of ‘U+3.0’ that creates data- and technology-based platforms and services centered around customers to discover future growth engines,” sa

Technology Sept. 15, 2022

The South Korean government has imposed a total of 100 billion won ($72 million) in fines against Google and Meta for illegally collecting and using personal information for customized advertisements, officials said Wednesday. The Personal Information Protection Commission under the Prime Minister's Office decided to impose fines of 69.2 billion won and 30.8 billion won against Google and Meta, respectively, after it held a plenary session earlier in the day. According to the PIPC’s inve

Technology Sept. 14, 2022

Naver Z, the metaverse affiliate of South Korean IT giant Naver, has joined the Tech Coalition to fight online sexual abuse and exploitation of children, the company said Wednesday. Established as a voluntary working group in 2006, the Tech Coalition is a global alliance of technology companies that have come together to better detect, report, remove and prevent online child sexual abuse. With Naver Z becoming the newest member of the alliance, there are now 28 companies including Amazon, Appl

Technology Sept. 14, 2022

Hanmi Pharmaceutical has scored its first approval from the US Food and Drug Administration with its novel biomedicine Rolontis. Rolontis -- Hanmi Pharmaceutical's treatment for neutropenia, a disease that occurs when a specific type of white blood cells is lacking so that the body cannot fight infections, especially those caused by bacteria -- was given the FDA’s approval on Friday, according to the Korean firm’s US partner Spectrum Pharmaceuticals’ announcement. Neutropenia's

Technology Sept. 13, 2022

Grand plans laid out by Seoul and Busan show how South Korea will play a major role as Asia's influence grows, according to futurist Richard Yonck. “One of the things that are very apparent to me is that a huge amount of the future is going to be happening through Asia,” Yonck, founder of Intelligent Future Consulting, told The Korea Herald in Seoul on Sept. 5. Mentioning the Seoul Vision 2030 plan and the government efforts to host the 2030 World Expo in Busan, the futurist said t

Technology Sept. 13, 2022

HLB’s precision cancer drug Rivoceranib has demonstrated the world’s longest median overall survival, or mOS, in phase 3 clinical trials of liver cancer, the South Korean biopharmaceutical company said Thursday. According to HLB, Rivoceranib’s mOS recorded 22.1 months to mark the first drug in the world to break the 20-month barrier against liver cancer. The company earlier released the abstract of phase 3 concomitant clinical trials of Rivoceranib and anticancer drug Camreli

Technology Sept. 8, 2022

SK Bioscience has completed the application for an emergency use listing of SKYCovione -- South Korea’s first homemade COVID-19 vaccine -- with the World Health Organization, the local vaccine developer said Thursday. The WHO’s emergency use listing is the global health body’s procedure for reviewing vaccines, therapeutics and in vitro diagnosis with the goal of expediting the availability of such products to people in case of a public health emergency. As the WHO’s asse

Technology Sept. 8, 2022

It has been almost 1,000 days since the first case of COVID-19 was reported from Wuhan, China, at the end of December 2019. The unprecedented pandemic swept the world. Humanity fought back fiercely. The world now appears to have an upper hand over the novel coronavirus as borders are crossed and masks are taken off. However, a global expert on immune therapies and vaccines says the COVID-19 pandemic is not done yet. “Everyone wishes (the pandemic) would go away but it really hasn’t

Technology Sept. 8, 2022

Hyundai Motor Group and KT have decided to exchange shares worth about 750 billion won ($541 million) to strengthen their partnership in the future mobility sector, officials said Wednesday. According to the two companies, Hyundai Motor Group will acquire 7.7 percent of KT’s treasury stock while KT will acquire 1.04 percent of Hyundai Motor Group’s treasury stock and 1.46 percent of Hyundai Mobis’ shares. The two companies decided to join hands in upgrading future mobility te

Industry Sept. 7, 2022